Document Detail

Ewing's sarcoma of a lower extremity in an infant. A therapeutic dilemma.
MedLine Citation:
PMID:  3708544     Owner:  NLM     Status:  MEDLINE    
A 5.5-month-old infant with Ewing's sarcoma of the left femur is described. The clinical and the pathologic features in this infant are presented in detail, and the dilemma faced in diagnosis and therapy of Ewing's sarcoma in infants is discussed. It is suggested that Ewing's sarcoma in an infant with a lower extremity lesion may be adequately managed without primary amputation.
T H Kim; G Zaatari; G O Atkinson; J R McLaren; A H Ragab
Related Documents :
22336194 - Study protocol: an early intervention program to improve motor outcome in preterm infan...
22499404 - Chest physical therapy is effective in reducing the clinical score in bronchiolitis: ra...
17710354 - Conditions mimicking coarctation of the aorta.
21521924 - Feeding obturator appliance for an infant with cleft lip and palate.
21617564 - Congenital hemophagocytic lymphohistiocytosis in a preterm infant: cytokine profile and...
21697884 - Diversity of the human skin microbiome early in life.
Publication Detail:
Type:  Case Reports; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Cancer     Volume:  58     ISSN:  0008-543X     ISO Abbreviation:  Cancer     Publication Date:  1986 Jul 
Date Detail:
Created Date:  1986-07-17     Completed Date:  1986-07-17     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0374236     Medline TA:  Cancer     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  187-9     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Femoral Neoplasms / drug therapy,  pathology,  radiotherapy*
Follow-Up Studies
Sarcoma, Ewing's / drug therapy,  pathology,  radiotherapy*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Cisplatin administered by the intracavitary route as treatment for malignant mesothelioma.
Next Document:  Multiple myeloma in Northern Israel, 1970-1979.